title: Structural insight into tetrameric hTRPV1 from homology modeling, molecular docking, molecular dynamics simulation, virtual screening, and bioassay validations.
abstract: The transient receptor potential vanilloid type 1 (TRPV1) is a heat-activated cation channel protein, which contributes to inflammation, acute and persistent pain. Antagonists of human TRPV1 (hTRPV1) represent a novel therapeutic approach for the treatment of pain. Developing various antagonists of hTRPV1, however, has been hindered by the unavailability of a 3D structure of hTRPV1. Recently, the 3D structures of rat TRPV1 (rTRPV1) in the presence and absence of ligand have been reported as determined by cryo-EM. rTRPV1 shares 85.7% sequence identity with hTRPV1. In the present work, we constructed and reported the 3D homology tetramer model of hTRPV1 based on the cryo-EM structures of rTRPV1. Molecular dynamics (MD) simulations, energy minimizations, and prescreen were applied to select and validate the best model of hTRPV1. The predicted binding pocket of hTRPV1 consists of two adjacent monomers subunits, which were congruent with the experimental rTRPV1 data and the cyro-EM structures of rTRPV1. The detailed interactions between hTRPV1 and its antagonists or agonists were characterized by molecular docking, which helped us to identify the important residues. Conformational changes of hTRPV1 upon antagonist/agonist binding were also explored by MD simulation. The different movements of compounds led to the different conformational changes of monomers in hTRPV1, indicating that TRPV1 works in a concerted way, resembling some other channel proteins such as aquaporins. We observed that the selective filter was open when hTRPV1 bound with an agonist during MD simulation. For the lower gate of hTRPV1, we observed large similarities between hTRPV1 bound with antagonist and with agonist. A five-point pharmacophore model based on several antagonists was established, and the structural model was used to screen in silico for new antagonists for hTRPV1. By using the 3D TRPV1 structural model above, the pilot in silico screening has begun to yield promising hits with activity as hTRPV1 antagonists, several of which showed substantial potency.
authors: Zhiwei
authors: Z
authors: Feng
authors: ⊥Laboratory of Cancer Biology and Genetics, National Cancer Institute, Bethesda, Maryland 20892, United States.
authors: Larry V
authors: LV
authors: Pearce
authors: Xiaomeng
authors: X
authors: Xu
authors: Xiaole
authors: X
authors: Yang
authors: Peng
authors: P
authors: Yang
authors: ⊥Laboratory of Cancer Biology and Genetics, National Cancer Institute, Bethesda, Maryland 20892, United States.
authors: Peter M
authors: PM
authors: Blumberg
authors: Xiang-Qun
authors: XQ
authors: Xie
mesh_terms: D000818:Animals; D001665:Binding Sites; D001667:Binding, Competitive; D016466:CHO Cells; D002118:Calcium / Q000378:metabolism; D002460:Cell Line; D003198:Computer Simulation; D003412:Cricetulus; D020285:Cryoelectron Microscopy; D004353:Drug Evaluation, Preclinical / Q000379:methods*; D006801:Humans; D008024:Ligands; D008958:Models, Molecular; D062105:Molecular Docking Simulation; D056004:Molecular Dynamics Simulation; D011487:Protein Conformation; D015203:Reproducibility of Results; D040681:Structural Homology, Protein; D050916:TRPV Cation Channels / Q000819:agonists / Q000037:antagonists & inhibitors / Q000737:chemistry* / Q000378:metabolism*
chemical_list: D008024:Ligands; D050916:TRPV Cation Channels; C494482:TRPV1 protein, human; D002118:Calcium
references: Nat Chem Biol. 2009 Aug;5(8):581-3
references: 19561620
references: Nucl Med Biol. 2013 Jan;40(1):141-7
references: 23141549
references: Nature. 2011 Jul 19;477(7366):549-55
references: 21772288
references: J Phys Chem B. 1998 Apr 30;102(18):3586-616
references: 24889800
references: Cell. 2009 Oct 16;139(2):267-84
references: 19837031
references: J Chem Inf Model. 2014 Sep 22;54(9):2483-99
references: 25141027
references: Eur J Med Chem. 2013 Jun;64:589-602
references: 23685943
references: J Chem Inf Model. 2012 Aug 27;52(8):2119-31
references: 22747061
references: Pharmacol Rev. 2012 Oct;64(4):939-71
references: 23023032
references: Nature. 2013 Dec 5;504(7478):107-12
references: 24305160
references: Curr Protoc Bioinformatics. 2008 Dec;Chapter 5:Unit 5.7
references: 19085979
references: J Chem Inf Model. 2007 Jul-Aug;47(4):1626-37
references: 17580929
references: Bioorg Med Chem Lett. 2014 Jan 1;24(1):382-5
references: 24321344
references: J Comput Aided Mol Des. 2011 Apr;25(4):317-27
references: 21448716
references: J Pharmacol Exp Ther. 2011 May;337(2):400-10
references: 21343315
references: J Biol Chem. 2004 May 7;279(19):20283-95
references: 14996838
references: Nature. 2013 Dec 5;504(7478):113-8
references: 24305161
references: J Med Chem. 2008 Jan 10;51(1):57-67
references: 18072720
references: Nature. 1999 Jul 29;400(6743):452-7
references: 10440374
references: J Mol Graph. 1996 Dec;14(6):354-60, 376
references: 9195488
references: J Comput Aided Mol Des. 1996 Oct;10(5):427-40
references: 8951652
references: Biophys J. 2002 Jul;83(1):154-60
references: 12080108
references: Science. 2011 Apr 15;332(6027):322-7
references: 21393508
references: J Biol Chem. 2004 Apr 23;279(17):17165-72
references: 14960593
references: Annu Rev Biophys Biomol Struct. 2000;29:291-325
references: 10940251
references: Biochemistry. 2004 Mar 9;43(9):2501-11
references: 14992587
references: Semin Cell Dev Biol. 2006 Oct;17(5):582-91
references: 17196854
references: Proteins. 2003 Nov 1;53(2):307-19
references: 14517981
references: Mol Pain. 2013 Jun 22;9:30
references: 23800232
references: J Med Chem. 2008 Feb 14;51(3):392-5
references: 18183945
references: Proteins. 2003 Feb 15;50(3):437-50
references: 12557186
references: Pain. 2007 Nov;132(1-2):132-41
references: 17659837
references: J Chem Phys. 2011 Feb 7;134(5):055110
references: 21303170
references: J Pharmacol Exp Ther. 2005 Apr;313(1):474-84
references: 15615864
references: Biochim Biophys Acta. 2011 Jun;1808(6):1581-6
references: 21315687
references: Nature. 2003 May 1;423(6935):33-41
references: 12721618
references: Proc Natl Acad Sci U S A. 2000 Jul 5;97(14):8134-9
references: 10859346
references: Nucleic Acids Res. 2012 Jan;40(Database issue):D1100-7
references: 21948594
references: Nucleic Acids Res. 2007 Jul;35(Web Server issue):W407-10
references: 17517781
references: Int J Mol Sci. 2012;13(7):8958-8969
references: 22942745
references: J Mol Graph Model. 2002 Aug;21(1):47-9
references: 12413030
references: Mol Pain. 2008 Oct 01;4:42
references: 18826653
references: J Chem Inf Model. 2012 Apr 23;52(4):1005-14
references: 22404225
references: Annu Rev Biochem. 2007;76:387-417
references: 17579562
references: Naunyn Schmiedebergs Arch Pharmacol. 2008 Apr;377(2):149-57
references: 18259730
references: J Chem Theory Comput. 2011 Jul 12;7(7):2284-95
references: 26606496
references: Nature. 2007 Nov 15;450(7168):376-82
references: 18004376
references: J Med Chem. 2012 Oct 11;55(19):8392-408
references: 22957803
references: J Chem Inf Comput Sci. 1998 May-Jun;38(3):511-22
references: 9611787